Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project.

Documenti analoghi

• A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class.
  di: Keith B Hoffman, et al.
  Pubblicazione: (2012-01-01)
• Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project.
  di: Sandra de Bie, et al.
  Pubblicazione: (2015-01-01)
• Hypersensitivity reactions to anticancer agents: Data mining of the public version of the FDA adverse event reporting system, AERS
  di: Sakaeda Toshiyuki, et al.
  Pubblicazione: (2011-10-01)
• Aspirin- and Clopidogrel-associated Bleeding Complications: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS
  di: Takao Tamura, Toshiyuki Sakaeda, Kaori Kadoyama, Yasushi Okuno
  Pubblicazione: (2012-01-01)
• Platinum Agent-Induced Hypersensitivity Reactions: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS
  di: Toshiyuki Sakaeda, Kaori Kadoyama, Hiroaki Yabuuchi, Satoshi Niijima, Kyoko Seki, Yukinari Shiraishi, Yasushi Okuno
  Pubblicazione: (2011-01-01)